HSP90AA1 and systemic lupus erythematosus: Since serum levels of IL-6 have been described to correlate with disease activity in both systemic lupus erythematosus and BP [32], [33], further studies of a more detailed analysis of the possibly pathophysiologically relevant IL-6-Hsp90 interplay in BP patients are warranted.